平安產險於深圳首批數字人民幣保單簽發業務
據《深圳特區報》報道,平安產險聯合中國銀行(03988.HK)深圳市分行,近日於深圳首批數字人民幣保單簽發業務。
是次合作是由平安產險深圳分公司爲深圳市南山區醫護人員開發「醫護人員綜合保險」,爲醫護人員提供30萬元人民幣(下同)專屬新冠身亡賠償金、5萬元新冠確診津貼及5萬元意外身故賠償金的保險保障,若投保人使用數字人民幣錢包進行支付,即可享受投保專屬優惠津貼。
平安產險深圳分公司相關負責人表示,未來將進一步探索數字人民幣在保險理賠、支付等環節的應用,打通數字人民幣在保險行業從保險投保到理賠結算的全流程服務,繼續擴大數字人民幣在保險行業的多場景運用模式。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.